NCT06517888 2026-04-06
Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma
Akouos, Inc.
Phase 1/2 Recruiting
Clinical Trials
69 trialsNCT07493447 2026-03-25
Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures
Vanderbilt-Ingram Cancer Center
Phase EARLY_PHASE1 Not yet recruiting
NCT05702749 2026-03-24
VS PREHAB
Medical College of Wisconsin
Phase NA Recruiting
NCT07479446 2026-03-18
Oliceridine Versus Sufentanil for Postoperative Nausea in Cerebellopontine Angle Surgery
Xuanwu Hospital, Beijing
Phase NA Not yet recruiting
NCT07364955 2026-01-23
Vestibular Rehabilitation Protocol in Unilateral Vestibular Schwannoma
Universitat Autonoma de Barcelona
Phase NA Recruiting
NCT06163664 2026-01-13
Role of ChatGPT in Vestibular Schwannoma Management
University of Southern California
Phase NA Withdrawn
NCT04374305 2026-01-12
INTUITT-NF2
Massachusetts General Hospital
Phase 2 Active not recruiting
NCT06322342 2025-12-26
Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent
Reveal Pharmaceuticals Inc.
Phase 2 Completed
NCT07305285 2025-12-26
Roy Adaptation Model Improves Mood and QOL After Giant Acoustic Neuroma
West China Hospital
Phase NA Completed
NCT03261726 2025-12-19
Maintaining Cochlear Patency After VIIIth Nerve Surgery
Henry Ford Health System
Phase NA Withdrawn
NCT03079999 2025-12-18
Study of Aspirin in Patients With Vestibular Schwannoma
Massachusetts Eye and Ear Infirmary
Phase 2 Active not recruiting
NCT02282917 2025-12-05
Exploratory Evaluation of AR-42 Histone Deacetylase Inhibitor in the Treatment of Vestibular Schwannoma and Meningioma
Massachusetts Eye and Ear Infirmary
Phase EARLY_PHASE1 Terminated
NCT07267910 2025-12-05
VESTI
Aalto University
Phase NA Not yet recruiting
NCT05622344 2025-11-10
SWAN
Johns Hopkins University
Phase NA Recruiting
NCT01199978 2025-10-01
Hearing Outcomes Using Fractionated Proton Radiation Therapy for Vestibular Schwannoma
Massachusetts General Hospital
Phase 2 Active not recruiting
NCT04057976 2025-09-12
Use of DTT to Define Facial Nerve Position in Vestibular Schwannomas
King's College Hospital NHS Trust
Phase NA Completed
NCT07130851 2025-08-19
Mapping of Vestibular Centers Activation Using fMRI in Patients With Vestibular Schwannoma
Charles University, Czech Republic
Phase NA Active not recruiting
NCT07116811 2025-08-12
SAF-NRVS
Beijing Tiantan Hospital
Phase 3 Not yet recruiting
NCT04743310 2025-06-13
Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System
Cedars-Sinai Medical Center
Phase 2 Completed
NCT06660082 2025-05-16
KINE HIT
Hospices Civils de Lyon
Phase NA Recruiting
NCT03095248 2025-04-22
SEL-TH-1601
Children's Hospital Medical Center, Cincinnati
Phase 2 Terminated
NCT04196933 2025-04-16
Analysis of Vestibular Compensation Following Clinical Intervention for Vestibular Schwannoma
Massachusetts Eye and Ear Infirmary
Phase NA Withdrawn
NCT01083966 2025-04-09
Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Vestibular Schwannoma
Northwell Health
Phase 1 Suspended
NCT02249572 2025-04-02
V-REX
Haukeland University Hospital
Phase NA Completed
NCT03795675 2025-03-19
CI Following VS Removal or Labyrinthectomy
Ohio State University
Phase NA Recruiting
NCT04594057 2025-03-19
Longitudinal Recovery of Laboratory, Clinical, and Community-Based Measures of Head and Trunk Control in People With Acquired Vestibulopathy
University of Utah
Phase NA Terminated
NCT06112509 2024-09-19
EVERS
Centre Hospitalier Universitaire de Besancon
Phase NA Recruiting
NCT06572475 2024-08-27
UMIC
Northern Care Alliance NHS Foundation Trust
Phase NA Recruiting
NCT04859335 2024-08-02
EQUI-GAMMA
University Hospital, Toulouse
Phase NA Recruiting
NCT04241679 2024-04-25
ANTS
Washington University School of Medicine
Phase NA Completed
NCT01938677 2024-04-18
Gamma Knife Radiosurgery vs Initial Conservative Treatment for Vestibular Schwannoma Patients With Preserved Hearing, a Prospective Randomized Study
Karolinska Institutet
Phase NA Completed
NCT01345136 2024-02-13
Study of RAD001 for Treatment of NF2-related Vestibular Schwannoma
Jonsson Comprehensive Cancer Center
Phase 2 Terminated
NCT04801953 2023-10-19
Nimodipine in Vestibular Schwanommas
Medical University of Vienna
Phase 2 Unknown
NCT05116878 2023-09-08
EFFORTS
Mayo Clinic
Phase NA Terminated
NCT04351373 2023-08-01
Microscopic Fluorescence-guided Vestibular Schwannoma Resection Using Fluorescein Sodium and YELLOW 560
Mayo Clinic
Phase 2 Completed
NCT03581331 2023-07-14
SVorthoptie
Assistance Publique Hopitaux De Marseille
Phase NA Completed
NCT03958006 2023-04-20
Simultaneous Cochlear Implantation During Translabyrinthine Resection of Vestibular Schwannoma
Henry Ford Health System
Phase NA Completed
NCT04890132 2023-03-16
Vestibular Precision: Physiology & Pathophysiology
Massachusetts Eye and Ear Infirmary
Phase NA Unknown
NCT05248113 2022-12-01
Intraoperative Electrically-evoked ABRs in Patients Undergoing Vestibular Schwannoma Surgery
University of California, Irvine
Phase NA Unknown
NCT05567341 2022-10-05
RIC-VS
University Hospital Tuebingen
Phase NA Unknown
NCT04658836 2022-08-24
Triamcinolone Levels in Cochlear Perilymph, Lateral Canal and CSF
Medical University of Vienna
Phase 1 Completed
NCT04148534 2022-06-29
Compare the Operating Condition of Two Levels of Muscle Relaxation on Facial Nerve MEP Monitoring in CPA Surgery
Cairo University
Phase NA Completed
NCT03057678 2022-01-20
PPF
Vanderbilt University Medical Center
Phase NA Withdrawn
NCT02129647 2021-12-01
Study of Axitinib in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas
NYU Langone Health
Phase 2 Completed
NCT02948790 2021-10-20
NeuriStim
Oticon Medical
Phase NA Completed
NCT02934256 2021-09-09
Icotinib
Beijing Tiantan Hospital
Phase 2 Completed
NCT02055859 2021-02-21
ACOUNEU
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Phase NA Unknown
NCT01125046 2021-01-22
Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas
Northwestern University
Phase 2 Completed
NCT00863122 2021-01-12
Concentration and Activity of Lapatinib in Vestibular Schwannomas
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase EARLY_PHASE1 Completed
NCT02379754 2020-09-11
Gentamicin Treatment Prior to Schwannoma Surgery - Residual Function
Lund University
Phase 4 Withdrawn